| - Industry | - Sector | Mr. Daniel Klain CEO | TASE Exchange | IL0010960495 ISIN |
| Israel Country | 33 Employees | 22 Mar 2017 Last Dividend | 1 Jun 2026 Last Split | - IPO Date |
Bio-View Ltd is a pioneering firm established in 1998, with its headquarters based in Rehovot, Israel. The company plays a crucial role in the field of biotechnology and medical diagnostics by focusing on the development, manufacturing, and international marketing of automated cell imaging and analysis solutions. These high-tech solutions primarily cater to cytology, cytogenetic, and pathology clinical and research laboratories. Its commitment to advancing healthcare through innovation is also highlighted by its partnership with ANGLE plc, aimed at developing a groundbreaking liquid biopsy circulating tumor cell HER2 assay for breast cancer.